Fundación Para La Investigación Del Hospital Clínico De Valencia
Clinical trials sponsored by Fundación Para La Investigación Del Hospital Clínico De Valencia, explained in plain language.
-
Potassium binder may unlock lifesaving heart drugs for seniors
Disease control Recruiting nowThis study tests whether a potassium-lowering drug called sodium zirconium cyclosilicate (Lokelma) can help elderly patients with heart failure and chronic kidney disease safely take higher doses of RAASi medications, which are often limited by high potassium levels. The trial wi…
Phase: PHASE3 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
One-Time iron infusion could boost recovery in elderly heart patients
Symptom relief Recruiting nowThis study is testing whether a single intravenous dose of iron can improve quality of life and reduce frailty in adults aged 65 and older who have iron deficiency after a heart attack. About 538 participants will be randomly assigned to receive either the iron infusion or standa…
Phase: PHASE4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Pacemaker study aims to boost stamina in stubborn heart failure
Symptom relief Recruiting nowThis study looks at whether a pacemaker can improve exercise ability and quality of life in people with heart failure with preserved ejection fraction (HFpEF) who also have a small heart chamber and a low heart rate during activity. About 30 participants will get a pacemaker and …
Phase: NA • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC